Literature DB >> 20548849

Expression of IL-10, TGF-beta(1) and TNF-alpha in Cultured Keratinocytes (HaCaT Cells) after IPL Treatment or ALA-IPL Photodynamic Treatment.

Ji Yeon Byun1, Hae Young Choi, Ki Bum Myung, You Won Choi.   

Abstract

BACKGROUND: Depending on the light dose and concentration of photosensitizer for photodynamic treatment (PDT), a multitude of dose-related events are demonstrable in PDT-treated cells. Sublethal doses may result in the alteration of cytokine release and consequently modify immune actions, rather than cause cell death.
OBJECTIVE: The purpose of this study was to investigate cytokine expression in cultured HaCaT cells after intense pulse light (IPL) treatment or PDT utilizing 5-aminolevulinic acid (ALA) and IPL at sublethal doses.
METHODS: Cultured HaCaT cells were treated with either IPL only (4, 8 and 12 J/cm(2)) or ALA-IPL PDT (100micromol/L of ALA; 0, 4, 8, and 12 J/cm(2) of IPL). The expression of IL-10, TGF-beta(1) and TNF-alpha was investigated by reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay.
RESULTS: IL-10 protein increased up to 5.95-fold after IPL treatment and up to 2.85-fold after PDT. TGF-beta(1) mRNA and protein showed slight increases after both IPL treatment and PDT, of which the latter induced slightly larger increases. TNF-alpha mRNA and protein showed no induction or reduction after PDT.
CONCLUSION: Increased expressions of IL-10 and TGF-beta(1) was observed after PDT. The induction of IL-10 may contribute to the anti-inflammatory effect, which explains the therapeutic benefit of PDT for inflammatory dermatoses, and that of TGF-beta(1) may be related to the therapeutic effect for psoriasis. The finding that IL-10 induction was more marked after IPL treatment than after PDT suggests that other mechanisms than IL-10 induction in keratinocytes after PDT may participate in the anti-inflammatory effect of PDT.

Entities:  

Keywords:  IL-10; Keratinocyte; Photodynamic therapy; TGF-β1; TNF-α

Year:  2009        PMID: 20548849      PMCID: PMC2883362          DOI: 10.5021/ad.2009.21.1.12

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  13 in total

Review 1.  Influence of photodynamic therapy on immunological aspects of disease - an update.

Authors:  D W Hunt; A H Chan
Journal:  Expert Opin Investig Drugs       Date:  2000-04       Impact factor: 6.206

2.  Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity.

Authors:  M O Obochi; L G Ratkay; J G Levy
Journal:  Transplantation       Date:  1997-03-27       Impact factor: 4.939

3.  Immunomodulatory aspects of photodynamic therapy.

Authors:  D W Hunt; J G Levy
Journal:  Expert Opin Investig Drugs       Date:  1998-01       Impact factor: 6.206

Review 4.  Photodynamic therapy in dermatology--an update.

Authors:  Philipp Babilas; Sigrid Karrer; Alexis Sidoroff; Michael Landthaler; Rolf-Markus Szeimies
Journal:  Photodermatol Photoimmunol Photomed       Date:  2005-06       Impact factor: 3.135

5.  IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response.

Authors:  S O Gollnick; D A Musser; A R Oseroff; L Vaughan; B Owczarczak; B W Henderson
Journal:  Photochem Photobiol       Date:  2001-12       Impact factor: 3.421

6.  Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.

Authors:  C Anderson; S Hrabovsky; Y McKinley; K Tubesing; H P Tang; R Dunbar; H Mukhtar; C A Elmets
Journal:  Photochem Photobiol       Date:  1997-05       Impact factor: 3.421

Review 7.  Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology.

Authors:  P G Calzavara-Pinton; M Venturini; R Sala
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-03       Impact factor: 6.166

8.  Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts.

Authors:  S Karrer; A K Bosserhoff; P Weiderer; M Landthaler; R-M Szeimies
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

9.  Photodynamic therapy in immune (non-oncological) disorders: focus on benzoporphyrin derivatives.

Authors:  L G Ratkay; J D Waterfield; D W Hunt
Journal:  BioDrugs       Date:  2000-08       Impact factor: 5.807

Review 10.  Acne and PDT: new techniques with lasers and light sources.

Authors:  Michael H Gold
Journal:  Lasers Med Sci       Date:  2007-01-16       Impact factor: 2.555

View more
  10 in total

1.  The Expressions of TGF-β(1) and IL-10 in Cultured Fibroblasts after ALA-IPL Photodynamic Treatment.

Authors:  Ji Yeon Byun; Ga Youn Lee; Hae Young Choi; Ki Bum Myung; You Won Choi
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

2.  Remodeling of dermal collagen in photoaged skin using low-dose 5-aminolevulinic acid photodynamic therapy occurs via the transforming growth factor-β pathway.

Authors:  Peiru Wang; Jiatong Han; Minglei Wei; Yuting Xu; Guolong Zhang; Haiyan Zhang; Lei Shi; Xiaojing Liu; Michael R Hamblin; Xiuli Wang
Journal:  J Biophotonics       Date:  2018-03-12       Impact factor: 3.207

3.  Growth inhibition effect of HMME-mediated PDT on hepatocellular carcinoma HepG2 cells.

Authors:  Lifeng Liu; Yuanjian Song; Limin Ma; Lixin Zang; Lili Tao; Zhiguo Zhang; Jiwu Han
Journal:  Lasers Med Sci       Date:  2014-05-06       Impact factor: 3.161

Review 4.  Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives.

Authors:  Giuseppe Giannaccare; Leonardo Taroni; Carlotta Senni; Vincenzo Scorcia
Journal:  Clin Optom (Auckl)       Date:  2019-10-17

5.  Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Authors:  M Barathan; V Mariappan; E M Shankar; B J J Abdullah; K L Goh; J Vadivelu
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

Review 6.  Intense pulsed light for evaporative dry eye disease.

Authors:  Steven J Dell
Journal:  Clin Ophthalmol       Date:  2017-06-20

7.  Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction.

Authors:  Steven J Dell; Ronald N Gaster; Sheila C Barbarino; Derek N Cunningham
Journal:  Clin Ophthalmol       Date:  2017-05-02

8.  Efficacy of Intense Pulsed Light Treatment for Moderate to Severe Acute Blepharitis or Blepharoconjunctivitis: A Retrospective Case Series

Authors:  Özgün Melike Gedar Totuk; Kerem Kabadayı; Cihan Özkapı; Ümit Aykan
Journal:  Turk J Ophthalmol       Date:  2021-04-29

9.  Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy.

Authors:  Mans Broekgaarden; Milan Kos; Freek A Jurg; Adriaan A van Beek; Thomas M van Gulik; Michal Heger
Journal:  Int J Mol Sci       Date:  2015-08-21       Impact factor: 5.923

10.  Hypericin-photodynamic therapy inhibits proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes cell line MH7A.

Authors:  Kun Zhang; Shan Gao; JiaYi Guo; GuoHua Ni; Zhe Chen; Feng Li; XiaoLei Zhu; YongBing Wen; YanXing Guo
Journal:  Iran J Basic Med Sci       Date:  2018-02       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.